v3.26.1
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net income $ 76,640,000 $ 56,403,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 22,787,000 21,993,000
Equity in losses/(earnings) of unconsolidated investments 123,000 (616,000)
Distributions from unconsolidated investments 812,000 616,000
Unrealized gains on marketable equity securities (9,989,000) (5,921,000)
Realized gains on sale of marketable securities (153,000) (480,000)
Gain on sale of property and equipment 0 (3,606,000)
Deferred income taxes (2,842,000) 1,406,000
Stock–based compensation 3,266,000 2,260,000
Changes in operating assets and liabilities:    
Accounts receivable 7,565,000 (6,736,000)
Inventories (403,000) 1,147,000
Prepaid expenses and other assets (585,000) (23,000)
Operating lease obligations 466,000 351,000
Trade accounts payable (2,759,000) (4,214,000)
Accrued payroll (3,581,000) 18,925,000
Amounts due to third party payors 1,129,000 (191,000)
Accrued risk reserves (466,000) 5,366,000
Other current liabilities 3,132,000 17,129,000
Other noncurrent liabilities 4,976,000 1,077,000
Net cash provided by operating activities 105,802,000 102,074,000
Cash Flows From Investing Activities:    
Purchases of property and equipment (22,167,000) (16,341,000)
Acquisition of skilled nursing facilities and other assets (54,698,000) 0
Deposits in escrow for real estate acquisition (20,000,000) 0
Collections of notes receivable 0 465,000
Investments in unconsolidated companies (6,984,000) (3,205,000)
Purchases of marketable securities (13,455,000) (47,276,000)
Proceeds from sale of marketable securities 15,747,000 43,455,000
Net cash used in investing activities (101,557,000) (22,902,000)
Cash Flows From Financing Activities:    
Repayments under credit facility (40,000,000) (27,000,000)
Dividends paid to common stockholders (19,930,000) (18,854,000)
Issuance of common shares 19,459,000 6,462,000
Repurchase of common shares (23,561,000) (6,384,000)
Noncontrolling interest distributions (453,000) 0
Entrance fee deposits 331,000 44,000
Net cash used in financing activities (64,154,000) (45,732,000)
Net Increase/(Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents (59,909,000) 33,440,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning of Period 112,187,000 96,922,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, End of Period 52,278,000 130,362,000
Balance Sheet Classifications:    
Cash and cash equivalents 39,209,000 110,992,000
Restricted Cash and Cash Equivalents 13,069,000 19,370,000
Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents $ 52,278,000 $ 130,362,000